Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic
Por:
Mortier, P, Vilagut, G, Ferrer, M, Alayo, I, Bruffaerts, R, Cristobal-Narvaez, P, del Cura-Gonzalez, I, Domenech-Abella, J, Felez-Nobrega, M, Olaya, B, Pijoan, JI, Vieta, E, Perez-Sola, V, Kessler, RC, Haro, JM, Alonso, J, Bonfill X., Molinero, E, Rius, C., MINDCOVID Working grp
Publicada:
17 feb 2021
Resumen:
Aims
To investigate the prevalence of suicidal thoughts and behaviours (STB; i.e. suicidal ideation, plans or attempts) in the Spanish adult general population during the first wave of the Spain coronavirus disease 2019 (COVID-19) pandemic (March-July, 2020), and to investigate the individual- and population-level impact of relevant distal and proximal STB risk factor domains.
Methods
Cross-sectional study design using data from the baseline assessment of an observational cohort study (MIND/COVID project). A nationally representative sample of 3500 non-institutionalised Spanish adults (51.5% female; mean age = 49.6 [s.d. = 17.0]) was taken using dual-frame random digit dialing, stratified for age, sex and geographical area. Professional interviewers carried out computer-assisted telephone interviews (1-30 June 2020). Thirty-day STB was assessed using modified items from the Columbia Suicide Severity Rating Scale. Distal (i.e. pre-pandemic) risk factors included sociodemographic variables, number of physical health conditions and pre-pandemic lifetime mental disorders; proximal (i.e. pandemic) risk factors included current mental disorders and a range of adverse events-experiences related to the pandemic. Logistic regression was used to investigate individual-level associations (odds ratios [OR]) and population-level associations (population attributable risk proportions [PARP]) between risk factors and 30-day STB. All data were weighted using post-stratification survey weights.
Results
Estimated prevalence of 30-day STB was 4.5% (1.8% active suicidal ideation; n = 5 [0.1%] suicide attempts). STB was 9.7% among the 34.3% of respondents with pre-pandemic lifetime mental disorders, and 1.8% among the 65.7% without any pre-pandemic lifetime mental disorder. Factors significantly associated with STB were pre-pandemic lifetime mental disorders (total PARP = 49.1%) and current mental disorders (total PARP = 58.4%), i.e. major depressive disorder (OR = 6.0; PARP = 39.2%), generalised anxiety disorder (OR = 5.6; PARP = 36.3%), post-traumatic stress disorder (OR = 4.6; PARP = 26.6%), panic attacks (OR = 6.7; PARP = 36.6%) and alcohol/substance use disorder (OR = 3.3; PARP = 5.9%). Pandemic-related adverse events-experiences associated with STB were lack of social support, interpersonal stress, stress about personal health and about the health of loved ones (PARPs 32.7-42.6%%), and having loved ones infected with COVID-19 (OR = 1.7; PARP = 18.8%). Up to 74.1% of STB is potentially attributable to the joint effects of mental disorders and adverse events-experiences related to the pandemic.
Conclusions
STB at the end of the first wave of the Spain COVID-19 pandemic was high, and large proportions of STB are potentially attributable to mental disorders and adverse events-experiences related to the pandemic, including health-related stress, lack of social support and interpersonal stress. There is an urgent need to allocate resources to increase access to adequate mental healthcare, even in times of healthcare system overload.
Study registration number
NCT04556565
Filiaciones:
Mortier, P:
IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Vilagut, G:
IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Ferrer, M:
IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Univ Autonoma Barcelona UAB, Barcelona, Spain
Alayo, I:
IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Pompeu Fabra Univ, Barcelona, Spain
Bruffaerts, R:
Katholieke Univ Leuven, Univ Psychiat Ctr, Ctr Publ Hlth Psychiat, Leuven, Belgium
Cristobal-Narvaez, P:
Parc Sanit St Joan Deu, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
del Cura-Gonzalez, I:
Univ Rey Juan Carlos, Madrid Hlth Serv REDISSEC, Res Unit Primary Care Management, Madrid, Spain
Domenech-Abella, J:
Parc Sanit St Joan Deu, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
Felez-Nobrega, M:
Parc Sanit St Joan Deu, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
Olaya, B:
Parc Sanit St Joan Deu, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
Pijoan, JI:
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Hosp Univ Cruces OSI EEC, Clin Epidemiol Unit, Bilbao, Spain
Vieta, E:
Univ Barcelona, IDIBAPS, CIBERSAM, Hosp Clin, Barcelona, Spain
Perez-Sola, V:
Univ Autonoma Barcelona UAB, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
Parc Salut Mar PSMAR, Barcelona, Spain
Kessler, RC:
Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA
Haro, JM:
Parc Sanit St Joan Deu, Barcelona, Spain
CIBER Salud Mental CIBERSAM, Madrid, Spain
Univ Barcelona UB, Barcelona, Spain
Alonso, J:
IMIM Inst Hosp Mar Invest Med, Hlth Serv Res Unit, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain
Bonfill X.:
Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barceona, Spain
Molinero, E:
Agència de Salut Pública de Barcelona, Barcelona, Spain
Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barceona, Spain
Rius, C.:
Agència de Salut Pública de Barcelona, Barcelona, Spain
Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barceona, Spain
gold, Green Accepted, Green Published
|